The Audio Journal of Oncology tracks down the half dozen leading stories breaking in Turin at ESTRO 2016—the annual meeting of the European Society for Radiotherapy and Oncology. Nicolle Rekers MSc., Maastricht University, Netherlands discusses the “Abscopal Effect” in which the potency of a new immunotherapy was enhanced within and beyond the field of co-administered radiation.
You may also like...
Gene expression and molecular pathways guide head and neck cancer therapies 24 Apr, 2013 Whole Brain Radiotherapy Does Not Benefit Patients with Brain Metastases from Lung Cancer—European Respiratory Society 2016 Congress 5 Sep, 2016 Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds 6 Feb, 2014 Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia 9 Apr, 2013
- Previous story ‘Rescanning’ Optimizes Pencil Beam Proton Delivery to Moving Lung Tumor
- Next story Can these Women with Breast Cancer Avoid Chemotherapy?
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014